DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Alivus Life Sciences Limited — Acquisition (including agreement to acquire)-XBRL

NSE 1 hr ago·8 Oct 2026, 9:52 am

Alivus Life Sciences

Alivus Life Sciences Limited has announced an agreement to acquire another company, a strategic move that the firm has disclosed to the stock exchanges. This acquisition marks a significant step in the company's growth strategy, potentially expanding its operational footprint or product portfolio.

For investors, this development is noteworthy as it signals Alivus's intent to strengthen its market position. The success of such acquisitions often depends on the target's integration and the company's ability to manage the associated financial and operational risks.

Investors should monitor the company's future disclosures regarding the target entity and the terms of the deal. Keeping an eye on how this strategic expansion impacts Alivus's financial performance will be key to understanding its long-term trajectory.